Join
Live feed
·
PRReleasevia Quantisnow
Coeptis Therapeutics Holdings Inc. logo

Coeptis Therapeutics Completes Exclusive License for Allogeneic Immuno-Oncology Platform and Clinical Stage Assets from Deverra Therapeutics

ByQuantisnow·Wall Street's wire, on your screen.
COEP· Coeptis Therapeutics Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track COEP (Coeptis Therapeutics Holdings Inc.) and more on Quantisnow.